Pharma Stocks Rated in Buy

Explore our handpicked list of Pharma Stocks with a 'Buy' rating from external analysts. These pharmaceutical and healthcare companies have been identified as having strong growth prospects and solid fundamentals, offering investors the opportunity to capitalize on the potential of the pharma market. (Analyst Data curated by S&P Global)

Filter

Sort by

Name
Analyst Rating
Price
Target Price
M Cap
Alpha
1Y Return
3Y Return
5Y Return
PE
Industry PE
PB
Beta
Div Yld
Net Profit Qtr
Net Profit QoQ %
Net Profit YoY %
Net Profit 3Y Change %
Rev Qtr (in Cr)
Rev QoQ (in %)
Rev 1Y change %
Rev 3Y change %
Profit Mar Qtr
Profit Mar QoQ
Profit Mar 1Y Change%
Profit Mar 3Y Change%
Sector
M Cap
ROE
ROCE
EPS
Volume
imgSun Pharmaceutical Industries Ltd
BUY

₹1,665.10

1981.44Large Cap6.64%13.48%103.69%237.61%36.5255.8616.410.60.83%2160.64 Cr-25.94%12.7%322.31%12815.58-4.62%10.51%44.77%19.89%-22.35%1.99%191.7%Basic Materials399513.2712.05%12.22%40.212567882
imgCipla Ltd
BUY

₹1,499.70

1648.67Large Cap-9.48%-2.71%59.85%128.63%22.9755.864.310.710.87%1225.02 Cr-22.65%46.55%73.04%6597.72-5.23%13.28%34.52%16.12%-18.38%29.37%28.64%Basic Materials121131.9415.5%20.1%51.471917041
imgTorrent Pharmaceuticals Ltd
BUY

₹3,167.20

3593.68Large Cap4.26%11.87%124.34%144.58%56.0955.8612.890.611.08%498 Cr-0.99%33.02%32.31%29095.32%11.51%34.02%15.44%-6%19.28%-1.28%Basic Materials107187.6320.43%20.4%48.94307885
imgMankind Pharma Ltd
BUY

₹2,288.80

2712.47Mid Cap-2.33%5.65%60.92%60.92%46.3855.869.560.64NA424.65 Cr10.44%48.26%50.17%3079.37-3.73%18.12%66.3%18.79%14.72%25.52%-9.7%Pharmaceuticals94465.3620.95%25.77%48.471223889
imgLupin Ltd
BUY

₹1,948.00

2259.97Mid Cap18.66%24.79%209.28%108.29%27.0755.863.580.80.49%782.38 Cr-8.9%332.35%57.63%5562.2-1%20.25%31.97%9.67%-7.98%259.55%19.44%Basic Materials88964.2811.92%13.96%42.47753312
imgAbbott India Ltd
BUY

₹31,620.00

33417.5Mid Cap10.97%17.76%74.47%100.7%055.8615.480.48NA367.04 Cr1.74%16.35%0%1604.59-0.6%14.52%0%14.18%2.35%1.6%0%Basic Materials67192.534.88%44.71%35.679994
imgAurobindo Pharma Ltd
BUY

₹1,097.20

1410.5Mid Cap-18.3%-11.59%105.45%39.48%18.3455.863.240.830.41%902.83 Cr6.77%64.4%-40.59%8381.126.18%16.68%17.06%10.93%0.56%40.89%-49.25%Basic Materials64289.1810.35%11.74%54.092471302
imgGlaxosmithkline Pharmaceuticals Ltd
BUY

₹3,213.50

3072Mid Cap20.47%26.64%112.23%123.53%58.9455.8625.010.651.88%262.87 Cr14.35%57.23%-45.27%974.372.63%8.56%14.37%24.74%11.42%44.84%-52.15%Basic Materials54438.6349.23%58.72%54.76123913
imgGlenmark Pharmaceuticals Ltd
BUY

₹1,636.70

1678.42Mid Cap25.3%33%339.26%214.9%44.1255.861.180.840.26%4.38 Cr-98.74%-479.84%-247.77%3220.13-2.48%1.98%7.94%-12.14%-98.71%-472.45%-236.9%Basic Materials46187.816.98%9.75%-50.81156671
imgBiocon Ltd
BUY

₹351.35

377.62Mid Cap-4.06%1.63%8.11%-9.34%41.4855.862.911.20.19%459.4 Cr466.46%101.84%53.37%4358.115.51%32.05%106.57%8.8%390.41%52.85%-25.76%Basic Materials42183.080.97%2.61%10.813627362
imgCohance Lifesciences Ltd
BUY

₹983.00

1313Mid Cap29.2%37.69%114.72%311.47%93.3555.868.380.68NA38.73 Cr-53.5%-26.99%-17.13%402.0230.89%-21.56%4.12%28.56%-64.47%-6.92%-20.41%Basic Materials37606.3514.31%18.82%11.81026900
imgIpca Laboratories Ltd
BUY

₹1,354.40

1540.67Mid Cap13.79%19.18%52.2%65.32%46.5755.864.950.850.32%65.78 Cr-76.28%7.58%-53.94%2246.690.06%23.39%42.16%6.87%-76.29%-12.82%-67.6%Basic Materials34361.79.81%14.12%20.86475316